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Dear Editor:
Iodine is a micronutrient required for normal thyroid function.
In the United States, recommended daily allowances (RDA) for
iodine intake are 150lg in adults, 220–250lg in pregnant
women, and 250–290lg in breastfeeding women (1,2). The
U.S. diet generally contains enough iodine to meet these needs,
with common sources being iodized salt, dairy products, some
breads, and seafood. During pregnancy and lactation, women
require higher amounts of iodine for the developing fetus and
infant. The American Thyroid Association (ATA) recommends
that women take a multivitamin containing 150lg of iodine
daily in the form of potassium iodide (KI) (3) during precon-
ception, pregnancy, and lactation to meet these needs (4).
Ingestion of greater than 1100lg of iodine per day (tolerable
upper limits for iodine) (1) is not recommended and may cause
thyroid dysfunction. During pregnancy and lactation, when the
risk of excess iodine are primarily related to the fetus and
newborn infant, the recommendations for the upper limit vary
and range from 500–1100lg of iodine daily (2). In particular,
infants, the elderly, pregnant and lactating women, and indi-
viduals with preexisting thyroid disease (such as autoimmune
Hashimoto’s disease, Graves’ disease, nontoxic thyroid nodules,
history of partial thyroidectomy, and other conditions) are sus-
ceptible to adverse effects of excess iodine intake and exposure
(5). The public is advised that many iodine, potassium iodide,
and kelp supplements contain iodine in amounts that are up to a
hundred times higher than the daily tolerable upper limits for
iodine. The ATA advises against the ingestion of iodine and kelp
supplements containing in excess of 500lg iodine daily for
children and adults and during pregnancy and lactation. Long-
term iodine intake in amounts greater than the tolerable upper
limits should be closely monitored by a physician. There are
only equivocal data supporting the benefit of iodine at higher
doses than these, including a possible benefit for patients with
fibrocystic breast disease (6). There is no known thyroid benefit
of routine daily iodine doses in excess of the U.S. RDA.
There are a limited number of medical conditions in
which the short-term use of high amounts of iodine is in-
dicated. Exceptions for the recommendations to not exceed
the tolerable upper limits include closely monitored patients
prescribed Lugol’s solution or saturated solution of potas-
sium iodide (SSKI) in their treatment of severe hyperthy-
roidism, such as thyroid storm and prior to surgery in
patients with Graves’ disease, and individuals in the vicinity
of a nuclear power plant who are recommended to take KI in
the event of a nuclear accident. SSKI is not indicated nor
recommended in individuals with thyroid nodules. Finally,
patients receiving the large amounts of iodine in iodinated
contrast dyes, as required for radiologic studies, should be
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monitored for iodine-induced thyroid dysfunction if risk
factors are present.
Key points include:
 Adequate iodine intake is required for normal thyroid
function.
 The recommended iodine intake in nonpregnant adults
is 150 lg daily.
 Pregnant and breastfeeding women should take a pre-
natal vitamin that contains 150lg of potassium iodine
daily.
 Given a tolerable upper limit of 1100 lg iodine daily,
ingestion of an iodine or kelp supplement containing in
excess of 500 lg iodine daily should not be done.
 Certain exceptions to these recommendations include
those for specific medical conditions, which usually
require only a limited number of doses for a short-term
duration; such individuals should be closely monitored
for thyroid dysfunction.
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